A Randomized, Blinded, and Similar Vaccine-controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of the 5-dose Program and 4-dose (2-1-1) Program of Freeze-dried Human Rabies Vaccine (Vero Cells)
Latest Information Update: 28 Nov 2023
At a glance
- Drugs Rabies vaccine-Anhui Zhifei Longcom Biopharmaceutical (Primary) ; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions; Pharmacodynamics; Registrational
- Acronyms Vero Cells
- Sponsors Anhui Zhifei Longcom Biopharmaceutical
- 22 Nov 2023 Planned End Date changed from 30 Oct 2023 to 30 Oct 2024.
- 22 Nov 2023 Planned primary completion date changed from 30 Sep 2023 to 30 Sep 2024.
- 22 Nov 2023 Status changed from recruiting to active, no longer recruiting.